LETTER TO THE EDITOR
Afamin as a diagnostic marker in type 2 diabetes mellitus: a new place under the sun?
 
More details
Hide details
 
Submission date: 2017-11-29
 
 
Acceptance date: 2018-01-15
 
 
Publication date: 2018-02-07
 
 
Arch Med Sci Civil Dis 2018;3(1):16-17
 
TOPICS
REFERENCES (6)
1.
Lichenstein HS, Lyons DE, Wurfel MM, et al. Afamin is a new member of the albumin, alpha-fetoprotein, and vitamin D-binding protein gene family. J Biol Chem 1994; 269: 18149-54.
 
2.
Jerkovic L, Voegele AF, Chwatal S, et al. Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression. J Proteome Res 2005; 4: 889-99.
 
3.
Dieplinger B, Egger M, Gabriel C, et al. Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma. Clin Chim Acta 2013; 425: 236-41.
 
4.
Kronenberg F, Kollerits B, Kiechl S, et al. Plasma concentrations of afamin are associated with the prevalence and development of metabolic syndrome. Circ Cardiovasc Genet 2014; 7: 822-9.
 
5.
Seeber B, Morandell E, Lunger F, Wildt L, Dieplinger H. Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome. Reprod Biol Endocrinol 2014; 12: 88.
 
6.
Kollerits B, Lamina C, Huth C, et al. Plasma concentrations of afamin are associated with prevalent and incident type 2 diabetes: a pooled analysis in more than 20,000 individuals. Diabetes Care 2017; 40: 1386-93.
 
ISSN:2451-0637
Journals System - logo
Scroll to top